MedImmune Ventures Overview
- Investor Type
-
Venture Capital
- Status
-
Inactive
- Investments
-
63
- Portfolio
-
2
- Exits
-
43
MedImmune Ventures General Information
Description
MedImmune Ventures was the corporate venture arm of MedImmune. The firm used to invest in private companies which develops small and large molecules, vaccines, pharmaceutical technologies and platforms. The firm also used to invest in the medical device, diagnostic, imaging and healthcare information technology companies which pertain to the discovery, development and commercialization of pharmaceutical products. It was established in 2002 and was based in Gaithersburg, Maryland.
Contact Information
Website
www.medimmuneventures.com
Year Founded
2002
Investor Status
Out of Business
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Venture Capital
Primary Office
- One MedImmune Way
- Gaithersburg, MD 20878
- United States
MedImmune Ventures Investments & Acquisitions (63)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| G1 Therapeutics | 01-Jul-2016 | Later Stage VC | 0000 | Biotechnology | Generating Revenue/Not Profitable | 000 000000 00 |
| G1 Therapeutics | 05-Feb-2015 | 00000 00000 | 0000 | Biotechnology | Generating Revenue/Not Profitable | 000 000000 00 |
| AesRx | 09-Dec-2013 | 00000 00000 | 00.000 | Biotechnology | Generating Revenue | 000000 0000000 00.0 |
| Astria Therapeutics | 15-Nov-2013 | 00000 00000 | 000.00 | Drug Discovery | Generating Revenue | 000000 0000000 00.0 |
| G1 Therapeutics | 16-Oct-2013 | 00000 00000 | 000.00 | Biotechnology | Generating Revenue/Not Profitable | 0000000 00000 00.0 |
| ADC Therapeutics | 15-Oct-2013 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue/Not Profitable | |
| Inotek Pharmaceuticals | 27-Sep-2013 | 00000 00000 | 000.00 | Drug Discovery | Profitable | 000000 0000000 00.0 |
| Astria Therapeutics | 27-Jun-2013 | 00000 00000 | 00.00 | Drug Discovery | Generating Revenue | 000000 0000000 00.0 |
| Ambit Biosciences | 15-May-2013 | IPO | 0000 | Pharmaceuticals | Clinical Trials - Phase 3 | 0000 000000 |
| Cerapedics | 12-Dec-2012 | Later Stage VC | 0000 | Biotechnology | Generating Revenue | 000000 00 00.0 |
MedImmune Ventures Exits (43)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Cerapedics | 01-Aug-2021 | Secondary Transaction - Private | |
| Elusys | 01-Aug-2021 | 000000000 00000000 | |
| NKT Therapeutics | 01-Aug-2021 | 000000000 00000000 | |
| BlinkBio | 01-Jul-2020 | 000 00 00000000 | |
| ADC Therapeutics | 15-May-2020 | 000 | 00000 |
| Melinta Therapeutics | 27-Dec-2019 | 0000000000: 000000 | |
| Hydra Biosciences | 01-Dec-2018 | 000000000000000000 | 000.00 |
| Inotek Pharmaceuticals | 04-Jan-2018 | 000000000000000000 | |
| Armaron Bio | 01-Jan-2018 | Bankruptcy: Liquidation | |
| Melinta Therapeutics | 03-Nov-2017 | Reverse Merger |
MedImmune Ventures Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
